Venus Remedies gets European patent for painkiller injection

India's Venus Remedies has been granted a patent by the European Patent Office for its drug Achnil, a once-a-day painkiller injection.

"This novel formulation based on NDDS (Novel Drug Delivery System) technology is going to fill the gap of long standing demand for better pain management therapy," said Venus Remedies Joint Managing Director Manu Chaudhry, in a statement. "Especially for aged population, it is not only going to reduce the number of pricks but will also drastically reduce the side effects associated with the use of NSAIDs."

Venus Remedies plans to commercialize Achnil, which has been developed over the past five years, through out-licensing of exclusive market rights major pharmaceutical companies, the company said in the release. It also said Achnil has completed Phase III clinical trials.

- read the release
- and a report on

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.